what is glp-1 drugs How medications are transforming diabetes and weight loss treatment How long should you take
Description
[DOI] [PubMed] [Google Scholar] 136.de Heer J, Holst JJ
N., Al-Ruqi, A
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
A report of nine incidences of progressive vision loss among people using semaglutide or tirzepatide, the study adds to a growing body of work examining the trend, but study investigators point out there was no way to link the use of these new agents directly to ophthalmic conditions reported
Diabetic kidney disease: a report From an ADA Consensus Conference
Some good news: Telogen effluvium is typically not considered permanent
